| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rallybio Corp | Director | Option (Right to Buy) | 16.5K | $29.2K | $1.77 | May 15, 2024 | Direct |
| Prime Medicine, Inc. | Director | Stock Option (right to buy) | 45K | Jun 12, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| RLYB | Rallybio Corp | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
| PRME | Prime Medicine, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| RLYB | Rallybio Corp | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
| RLYB | Rallybio Corp | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
| PRME | Prime Medicine, Inc. | Oct 19, 2022 | 1 | $0 | 4 | Oct 21, 2022 | Director |
| PRME | Prime Medicine, Inc. | Oct 19, 2022 | 0 | $0 | 3 | Oct 19, 2022 | Director |
| RLYB | Rallybio Corp | Aug 1, 2022 | 1 | $0 | 4 | Aug 3, 2022 | Director |
| RLYB | Rallybio Corp | Aug 1, 2022 | 0 | $0 | 3 | Aug 3, 2022 | Director |